Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China

BACKGROUND: Few pharmacodynamics studies to date have evaluated the efficacy and safety of polymyxin B (PMB) in treating patients with bloodstream infections (BSIs) in China. METHODS: Patients with BSIs were identified using an antimicrobial surveillance network, and their pathogens were isolated. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xingbing, Huang, Chen, Wang, Hui, Ji, Jinru, Ying, Chaoqun, Xiao, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216662/
https://www.ncbi.nlm.nih.gov/pubmed/34168431
http://dx.doi.org/10.2147/DDDT.S313714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216662/
https://www.ncbi.nlm.nih.gov/pubmed/34168431
http://dx.doi.org/10.2147/DDDT.S313714

Ejemplares similares